916 related articles for article (PubMed ID: 24299555)
1. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers.
Joshi M; Monson TP; Joshi A; Woods GL
Ann Am Thorac Soc; 2014 Mar; 11(3):296-302. PubMed ID: 24446969
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
4. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
8. Screening for Mycobacterium tuberculosis infection among healthcare workers in New Zealand: prospective comparison between the tuberculin skin test and the QuantiFERON-TB Gold In-Tube assay.
Freeman JT; Marshall RJ; Newton S; Austin P; Taylor S; Chew TC; Gavaghan S; Roberts SA
N Z Med J; 2012 Feb; 125(1349):21-9. PubMed ID: 22327155
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tuberculin skin testing and QuantiFERON-TB Gold-In Tube test in health care workers.
Cağlayan V; Ak O; Dabak G; Damadoğlu E; Ketenci B; Ozdemir M; Ozer S; Saygı A
Tuberk Toraks; 2011; 59(1):43-7. PubMed ID: 21554229
[TBL] [Abstract][Full Text] [Related]
10. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers.
Gandra S; Scott WS; Somaraju V; Wang H; Wilton S; Feigenbaum M
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1279-85. PubMed ID: 20979495
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.
Arend SM; Thijsen SF; Leyten EM; Bouwman JJ; Franken WP; Koster BF; Cobelens FG; van Houte AJ; Bossink AW
Am J Respir Crit Care Med; 2007 Mar; 175(6):618-27. PubMed ID: 17170386
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
[TBL] [Abstract][Full Text] [Related]
13. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.
Tanabe M; Nakamura A; Arai A; Yamasaki D; Hirano K; Kobayashi T; Taguchi O; Kaneko T; Ito M
Intern Med; 2017; 56(7):773-779. PubMed ID: 28381742
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
[TBL] [Abstract][Full Text] [Related]
15. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
17. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
19. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
20. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
